Medicine and Dentistry
Aromatase Inhibitor
100%
Letrozole
87%
Breast Cancer
75%
Agonist
75%
Combination Therapy
62%
Neoplasm
37%
Estrogen Receptor
25%
Tumor Progression
25%
Growth
25%
Therapeutic Procedure
25%
Phosphorylation
12%
Xenograft
12%
Cyclin D1
12%
Cancer Inhibition
12%
S Phase
12%
Antiestrogen
12%
Breast Carcinogenesis
12%
P21
12%
Cell Cycle Progression
12%
CDK Inhibitor
12%
Mitogen-Activated Protein Kinase
12%
Biochemistry, Genetics and Molecular Biology
Aromatase Inhibitor
100%
Letrozole
87%
Growth
50%
Agonist
37%
Estrogen Receptor
25%
Electric Potential
25%
Phosphorylation
12%
Cancer Cell
12%
Carcinogenesis
12%
S Phase
12%
Cyclin D1
12%
Mitogen-Activated Protein Kinase
12%
P21
12%
Cell Cycle Progression
12%
Growth Inhibition
12%
Mouse
12%
Cyclin-Dependent Kinase
12%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatase Inhibitor
100%
Letrozole
87%
Breast Cancer
75%
Neoplasm
37%
Tumor Growth
25%
Combination Therapy
12%
Antiestrogen
12%
Mouse
12%
Cancer Inhibition
12%
Cyclin D1
12%
Breast Carcinogenesis
12%
Immunology and Microbiology
Breast
87%
Growth
50%
Agonist
37%
Electric Potential
25%
Cell Cycle Progression
12%
Cancer Cell
12%
Phosphorylation
12%
Growth Inhibition
12%
Xenograft
12%
Cyclin D1
12%
Mouse
12%
Veterinary Science and Veterinary Medicine
Aromatase Inhibitor
100%
Letrozole
87%
Estrogen Receptor
25%
Antiestrogen
12%
Cancer Cell
12%